Skip to main content

Press Releases

May 19, 2021
Washington, D.C. (May 19, 2021) —Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, delivered the following opening statement at today's hybrid hearing with Mr. Robert Kramer, President and Chief Executive Officer of Emergent BioSolutions, Inc.
May 19, 2021

Washington, D.C. (May 19, 2021) — Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, and Rep. Carolyn B.

May 13, 2021
Washington, D.C. (May 13, 2021) — Today, Rep. James E.
May 12, 2021

Washington, D.C. (May 12, 2021) — On Wednesday, May 19, 2021, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, will hold a hybrid in-person / remote hearing with Mr. Robert Kramer, President and Chief Executive Officer of Emergent BioSolutions, Inc. (Emergent), and Mr. Fuad El-Hibri, Executive Chairman of Emergent.

May 11, 2021
Washington, D.C. (May 11, 2021) — Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, and Rep.
April 19, 2021

Washington, D.C. (April 19, 2021)—Today, Rep. Carolyn B. Maloney, Chairwoman of the House Committee on Oversight and Reform, and Rep. James E.

April 15, 2021

Washington, D.C. (April 15, 2021) — Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, held a hearing with Centers for Disease Control and Prevention (CDC) Director Rochelle P. Walensky, National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S.